Role of MT1A Polymorphism and Environmental Mercury Exposure on the Montreal Cognitive Assessment (MoCA).
MT1A
blood mercury
genetic variations
mild cognitive impairment
Journal
Neuropsychiatric disease and treatment
ISSN: 1176-6328
Titre abrégé: Neuropsychiatr Dis Treat
Pays: New Zealand
ID NLM: 101240304
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
05
2021
accepted:
24
06
2021
entrez:
30
7
2021
pubmed:
31
7
2021
medline:
31
7
2021
Statut:
epublish
Résumé
Many age-related structural and functional changes in the brain have important consequences. Long-term exposure to mercury and the impact of functional polymorphisms of metal-regulating proteins such as metallothioneins (MTs) can result in neurological-neurobehavioral effects in elderly individuals. Therefore, the aims of this study are to examine the associations between biomarkers of mercury exposure and cognitive impairment and to investigate the effect of the rs8052394 single nucleotide polymorphism (SNP) of the potential modifier gene MT1A on different domains of the Montreal Cognitive Assessment (MoCA). We studied 436 participants aged ≥55 years from the Electricity Generating Authority of Thailand study. They underwent a physical examination, an extensive cognitive assessment with the MoCA (cutoff <26 points), and a biochemical analysis related to diabetes and dyslipidemia. The blood mercury level was determined by inductively coupled plasma mass spectrometry. Genotyping of the MT1A rs8052394 SNP was performed by the restriction fragmentation length polymorphism method. The mean age of the study population was 58.8±3.01 years, and most had ≥12 years of education (75.7%). The primary study finding was that the prevalence of mild cognitive impairment (MCI) in older Thai adults was 39.7%. The frequency distributions of the G allele of the rs8052394 SNP of the MT1A gene were significantly associated with the total and sub-domain MoCA scores. The prevalence of MCI was significantly associated with increased age, hypertriglyceridemia, hyperhomocysteinemia, the third tertile of blood mercury concentration, and the rs8052394 variant genotype of MT1A (P values for all odds ratios <0.05). These findings suggested that neurocognitive effects associate with mercury exposure and genetic susceptibility in toxicokinetics. Public health strategies can be used to implement as a comprehensive action plan to educate vulnerable populations on how to reduce mercury exposure. Concurrently, impact of such genetic predisposition requires replication for identifying and protecting susceptible individuals from mercury toxicity.
Identifiants
pubmed: 34326641
doi: 10.2147/NDT.S320374
pii: 320374
pmc: PMC8314684
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2429-2439Informations de copyright
© 2021 Sirivarasai et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest associated with this work.
Références
Am J Physiol Endocrinol Metab. 2008 May;294(5):E987-92
pubmed: 18349110
Int Arch Occup Environ Health. 2018 Feb;91(2):185-193
pubmed: 29030686
Ageing Res Rev. 2006 Aug;5(3):221-38
pubmed: 16950665
JAMA. 2005 Apr 20;293(15):1875-82
pubmed: 15840862
Metallomics. 2012 Aug;4(8):739-50
pubmed: 22791193
Can J Neurol Sci. 2018 Nov;45(6):620-623
pubmed: 30278852
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Am J Geriatr Psychiatry. 2012 Oct;20(10):854-65
pubmed: 22673190
Arch Clin Neuropsychol. 2012 Mar;27(2):165-75
pubmed: 22277128
Metallomics. 2016 Jan;8(1):71-81
pubmed: 26583802
Metallomics. 2014 Jan;6(1):55-68
pubmed: 24068159
Biol Trace Elem Res. 2019 Feb;187(2):341-356
pubmed: 29777524
Curr Environ Health Rep. 2015 Jun;2(2):179-94
pubmed: 26231367
Curr Alzheimer Res. 2007 Apr;4(2):123-6
pubmed: 17430234
Crit Rev Toxicol. 2006 Sep;36(8):609-62
pubmed: 16973445
Nucleic Acids Res. 2014 Jan;42(Database issue):D401-7
pubmed: 24293645
Sci Total Environ. 2020 Feb 25;705:135911
pubmed: 31838411
FEBS Lett. 2018 Mar;592(5):679-691
pubmed: 29323696
Int J Environ Res Public Health. 2016 Sep 01;13(9):
pubmed: 27598185
Environ Health Perspect. 2012 Apr;120(4):530-4
pubmed: 22233731